References
Korner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48:736–43.
Korner M, Christ E, Wild D, Reubi JC. Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Front Endocrinol. 2012;3:158.
Christ E, Wild D, Forrer F, Brandle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94:4398–405.
Sowa-Staszczak A, Pach D, Mikolajczak R, Macke H, Jabrocka-Hybel A, Stefanska A, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging. 2013;40:524–31.
Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, et al. Detection of metastatic insulinoma by positron emission tomography with [68Ga]exendin-4 – a case report. J Clin Endocrinol Metab. 2014;99(5):1519–24.
Acknowledgments
This work was partly supported by a Special Scientific Research Fund for Public Welfare Professions of China (201402001) and NIBIB intramural research program.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yaping Luo and Miao Yu contributed equally to the article.
Rights and permissions
About this article
Cite this article
Luo, Y., Yu, M., Pan, Q. et al. 68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake. Eur J Nucl Med Mol Imaging 42, 531–532 (2015). https://doi.org/10.1007/s00259-014-2946-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-014-2946-9